SCHEMBL8291336

SCHEMBL8291336

CC(=O)[C@@H]1CC2(CN1)OCCO2

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
GRM2 Q14416 1/20 0.32
GRM3 Q14832 1/20 0.32
CYP1A2 P05177 1/20 0.32
ALOX15 P16050 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8291342 0.92 GRM2 (0.31) GRM2GRM3CYP1A2ALOX15
SCHEMBL7380804 0.84 CYP1A2 (0.48) GRM2GRM3CYP1A2ALOX15
SCHEMBL8577271 0.84 CYP1A2 (0.48) GRM2GRM3CYP1A2ALOX15
SCHEMBL26114376 0.84 CYP1A2 (0.48) GRM2GRM3CYP1A2ALOX15
SCHEMBL10270050 0.82 GRM2 (0.35) GRM2GRM3CYP1A2ALOX15
SCHEMBL26114807 0.82 GRM2 (0.35) GRM2GRM3CYP1A2ALOX15
SCHEMBL18129434 0.82 BACE1 (0.42)
SCHEMBL7018907 0.82 BACE1 (0.42)
SCHEMBL18135074 0.82 BACE1 (0.42)
Hydrochloric Acid SCHEMBL22468429 0.80 BACE1 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1385870-B1 PEPTIDES AS NS3-SERINE PROTEASE INHIBITORS OF HEPATITIS C VIRUS SCHERING CORP (US) 2010-03-17 EP disclosed
EP-1467989-B1 PROLINE COMPOUNDS AS NS3-SERINE PROTEASE INHIBITORS FOR USE IN TREATMENT OF HEPATITIS C VIRUS INFECTION SCHERING CORP (US) 2009-09-23 EP disclosed
WO-2005030796-A1 MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS NS3 SERINE PROTEASE SCHERING CORPORATION (US) 2005-04-07 WO disclosed
WO-2005021584-A2 NOVEL PEPTIDOMIMETIC NS3-SERINE PROTEASE INHIBITORS OF HEPATITIS C VIRUS SCHERING CORPORATION (US) 2005-03-10 WO disclosed
WO-2003062265-A2 NOVEL PEPTIDES AS NS3-SERINE PROTEASE INHIBITORS OF HEPATITIS C VIRUS SCHERING CORPORATION (US) 2003-07-31 WO disclosed